Cabot (CBT) EBITDA (2009 - 2026)

Cabot (CBT) has reported EBITDA for 18 consecutive years, with $98.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBITDA fell 41.32% year-over-year to $98.0 million in Q2 2026; TTM through Jun 2026 was $493.0 million, a 22.24% decrease from a year earlier, with the FY2025 full-year figure at $621.0 million, up 1.14% from the prior year.
• EBITDA was $98.0 million for Q2 2026 at Cabot, down from $129.0 million in the prior quarter.
• Over five years, EBITDA peaked at $172.0 million in Q2 2024 and troughed at $98.0 million in Q2 2026.
• A 5-year average of $143.8 million and a median of $146.5 million in 2022 frame the typical range for EBITDA.
• Across the five-year window, EBITDA jumped 226.51% in 2022 and slumped 41.32% in 2026, its largest moves.
• Over 5 years, EBITDA stood at $105.0 million in 2022, then advanced by 29.52% to $136.0 million in 2023, then rose by 13.97% to $155.0 million in 2024, then retreated by 16.77% to $129.0 million in 2025, then decreased by 24.03% to $98.0 million in 2026.
• The last three EBITDA figures came in at $98.0 million (Q2 2026), $129.0 million (Q1 2026), and $129.0 million (Q4 2025), per Business Quant data.